Novel Therapeutic Approaches to WM-Preclinical

The following abstracts represent the presentations given at IWWM-7 Newport, Session-7:

Session Chair: Dr. Mitsiades

Targeting WM with BTK inhibitors  Dr. Tai (USA)

Targeting WM with MYD88 and IRAK inhibitors  Dr. Yang (USA)

Novel E3 Ligase and Proteasome Inhibitors for WM therapy  Dr. Mitsiades (USA)

Targeting the TLR/IL1-R Signaling Pathway  Dr. Sette (Italy)

Transgenic Mouse Model for WM utilizing MYD88 L265P  Dr. Carrasco (USA)